Close
close
June 17th, 2004

Focus on FOCIS!


From July 18-23, Montreal, Canada will host the 12th International Congress of Immunology. This meeting has been jointly organised by the International Union of Immunological Societies (IUIS), Canadian Society of Immunology (CSI) and the Federation of Clinical Immunology Societies (FOCIS) and will highlight many of the challenges that face immunologists in the 21st century.

The scientific programme will blend basic science, immunology research and clinical practice in the fields of immune regulation, immune intervention, host resistance to infection & malignancy, immunodiagnosis and immunogenetics.

Through a mixture of major, mini and clinical symposia, keynote addresses, workshops and a daily "Future Challenges" discussion, immunologists from around the world will be able to update themselves with cutting edge developments.

Montreal: venue for the 2004
FOCIS meeting

Octapharma´s support of the meeting will include a strong presence at the commercial exhibition and sponsorship of a lunch-time tutorial on Wednesday July 21st.



During this educational tutorial, leading European virologist, Professor T.F. Schwarz from Würzburg, Germany will address the highly emotive question: IGIV: How Safe is Your Product?

HIV, West Nile Virus, SARS, vCJD ...each year seems to bring a new threat to the blood supply and with it the risk for pathogen transmission through IGIV preparations.

How can you be sure that the product you use is safe?

Are there safety differences between brands?

These questions and more will be addressed by leading European virologist Prof. Tino Schwarz.
All delegates are encouraged to visit Octapharma at Booth #1421, where you can learn more about the tutorial, enter a prize draw, and obtain specialist information about Octagam, our 4th generation state-of-the-art IGIV, recently licensed by the US FDA.


For more information on the congress click here
(Please note that clicking on this link will take you outside of the Octapharma web site)


© Octapharma AG, 2004